Press release
Kidney Cancer Drugs Market Trends, outlook and Opportunity Analysis 2020
The global market for kidney cancer drugs is predicted to clock steady growth in the upcoming years because of an increasing geriatric population and higher prevalence of kidney cancer. As per the American Cancer Society, those afflicted with kidney cancer are mostly in the higher age bracket. The average age of people diagnosed with the malady is 64. Kidney cancer is very uncommon in people under the age of 45. The organization also finds that kidney cancer is one of the 10 most common cancers in both men and women.
View and Download TOC of Kidney Cancer Drugs Market Research Report@ https://www.transparencymarketresearch.com/report-toc/537
Approval of novel drug molecules is also serving to catalyze growth in the global kidney cancer drugs market. Posing a challenge to the market, on the contrary, is the growing sales of generic drug variants on account of expensiveness of branded cancer drugs.
A trend noticed in the global market for kidney cancer drugs is the manufacturers shifting their gaze towards developing economies to bring about sales growth.
North America Market Leads on the Back of Commercial Availability of Drugs from Prominent Brands
Depending upon the prominent brands of drugs, the global market for kidney cancer drugs can be segmented into Avastin (Bevacizumab), Afinitor (Everolimus), Inlyta (Axitinib), Torisel (Temsirolimus), Nexavar (Sorafenib), Sutent (Sunitinib), Proleukin (Aldesleukin/Interleukin-2), and Votrient (Pazopanib). Of them, Sutent, which is the marketed version of Sunitinib – Pfizer’s drug in the global kidney cancer drugs market, raked in maximum revenue in 2013. This is because Sutent is mainly prescribed as the first-line of treatment against kidney cancer. Sutent is also among the most studied drugs in its class for multiple indications, as it targets multiple receptor tyrosine kinases (RTKs).
Geography-wise, the key segments of the global market for kidney cancer drugs are North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America, among them, accounts for maximum market share owing to most prominent brands of kidney cancer treatment drugs being commercially available. In addition, a substantial number of patients and a solid healthcare system tailor-made for the pharmaceutical industry is also majorly fuelling the market in the region. North America accounted for 45% of market share in 2013.
Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=537
The global kidney cancer drugs market is dominated by a few global giants, namely F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, GlaxoSmithKline plc, and Pfizer, Inc. This makes the competitive landscape highly consolidated in nature. Competition among the players is stiff too.
Biopharmaceutical behemoth Pfizer, Inc., among them, led the global market for kidney cancer drugs with maximum share in 2013 on the back of Sunitinib and Axitinib, two of the main drugs used for treating kidney cancer. Other big names in the industry, such as Novartis and GSK too are adopting other strategies to increase their geographical outreach. They are focusing on bolstering their distribution networks in the relatively underserved markets in the emerging nations that are seeing an increasing prevalence of kidney cancer cases.
Buy Full Kidney Cancer Drugs Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=537<ype=S
About TMR
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Drugs Market Trends, outlook and Opportunity Analysis 2020 here
News-ID: 754697 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Kidney
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
Kidney Cancer Association Partners with Conquer Cancer Foundation to Fund Kidney …
For over a decade, the Kidney Cancer Association has assisted with funding the Conquer Cancer Foundation of ASCO's Young Investigator Award. The award provides funding to promising doctors to pursue careers in kidney cancer research.
“Conquer Cancer truly appreciates the generous and ongoing support of the Kidney Cancer Association as we work together to advance cutting-edge research and treatments for kidney cancer. We value this partnership which supports kidney cancer research…
Kidney Cancer Drugs Market: Rising Incidence of Kidney Cancer Expected to Boost …
With only a handful of large vendors accounting collectively for a large share, the vendor landscape of the global market for kidney cancer drugs can be viewed as largely consolidated and tough to crack for new vendors, observes Transparency Market Research in a recent report. The level of competition among leading players is also quite stiff.
Among the leading players, Pfizer, Inc. accounted for the maximum share in the overall market…
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA
Major scientific sessions:
Kidney Fluid, Electrolytes, Acid-Base Disorders
Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders
Chronic Kidney Disease (CKD) Kidney and Bladder stones
Dialysis and Renal Care Urology/Urinary Tract Infections
Kidney Transplantation Geriatric-Genetic Kidney…
